Back
Lexaria Bioscience Corp. Stock Predictions
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
44
LEXX
Lexaria Bioscience Corp.
Last Price:
$1.13
Seasonality Move:
0.34%
7 Day Trial
ALL ACCESS PASS
$
7
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiLexaria Bioscience Corp. Stock Forecast
-
Is Lexaria Bioscience Corp. Stock Undervalued?The current Lexaria Bioscience Corp. [LEXX] share price is $1.12. The Score for LEXX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
LEXX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Lexaria Bioscience Corp. Stock Go Up Next Year?
Data Unavailable
Lexaria Bioscience Corp. Stock Rating
Data Unavailable
Lexaria Bioscience Corp. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Canada
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
lexariabioscience.com
52-Week Data
52-Week High:
2.61
52-Week Low:
0.77
Prediction Charts
Market Cap:
24.9M
Price in USD:
1.12
Volume:
212.9K
Beta:
1.14
Technical Analysis
SMA50:
1.01
SMA100:
0.99
SMA200:
1.11
52-Wk Change:
-56.76%
Stock Predictions
-
Is Lexaria Bioscience Corp. stock public?Yes, Lexaria Bioscience Corp. is a publicly traded company.
-
What is the Lexaria Bioscience Corp. stock quote today?The Lexaria Bioscience Corp. stock price is 1.12 USD today.
-
How to buy Lexaria Bioscience Corp. stock online?You can buy Lexaria Bioscience Corp. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 1.08 | 1.06 | 1.09 | 1.03 |
| Nov-17 | 1.05 | 1.01 | 1.08 | 0.97 |
| Nov-18 | 1.03 | 1.05 | 1.05 | 0.99 |
| Nov-19 | 1.05 | 1.10 | 1.12 | 1.04 |
| Nov-20 | 1.12 | 1.11 | 1.19 | 1.09 |
| Nov-21 | 1.14 | 1.05 | 1.14 | 1.04 |
| Nov-24 | 1.05 | 1.06 | 1.06 | 1.00 |
| Nov-25 | 1.04 | 1.08 | 1.09 | 1.03 |
| Nov-26 | 1.08 | 1.12 | 1.15 | 1.04 |
| Nov-28 | 1.11 | 1.09 | 1.11 | 1.06 |
| Dec-1 | 1.09 | 1.06 | 1.11 | 1.05 |
| Dec-2 | 1.08 | 1.06 | 1.10 | 1.00 |
| Dec-3 | 1.05 | 1.11 | 1.12 | 1.02 |
| Dec-4 | 1.09 | 1.12 | 1.17 | 1.06 |
Lexaria Bioscience Corp. Earnings
Data Unavailable
Lexaria Bioscience Corp. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.00 per share.
* Lexaria Bioscience Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.